Bardet-Biedl Syndrome is a rare genetic condition. It affects how the body grows and works. People with this syndrome often have vision problems, extra fingers or toes, and are usually very heavy. It's a serious condition that needs careful management.
Every report comes from a Lived member, sent anonymously.
No reports yet
Add what worked for you with the search bar below
Bardet-Biedl syndrome (BBS) is a rare inherited condition that affects many parts of the body. Its best-known features are gradual loss of vision, weight gain that starts in early childhood, extra fingers or toes, kidney problems and difficulties with learning. Genital and hormone differences, delayed speech, dental differences and a reduced sense of smell are also common. Vision loss is the feature almost everyone shares. More than nine in ten people with BBS develop a progressive disease of the retina, the light-sensing layer at the back of the eye, which usually starts with poor night vision in childhood. Beyond that, the mix and severity of features vary a great deal, even between brothers and sisters, and they appear at different ages rather than all at once. That variability is one reason BBS is often recognized only after several features have shown up.
BBS is genetic. It is caused by changes in any one of at least 26 genes that help build and run primary cilia, tiny antenna-like structures on the surface of most cells that pick up signals from outside the cell. Because so many tissues depend on cilia, including the retina, the kidneys and the developing hands and feet, a fault in them shows up in many organs at once. Conditions caused this way are called ciliopathies. BBS is inherited in an autosomal recessive pattern: a person has it only when both copies of the same gene are altered, one from each parent. Parents are usually healthy carriers who did not know they carried a variant. When both parents are carriers, each pregnancy has a 1 in 4 chance of a child with BBS. The BBS1 and BBS10 genes account for the largest share of cases. The gene involved shapes the outlook somewhat. On average, people with BBS1 variants have milder kidney and metabolic problems, while variants in BBS10 and related genes carry a higher risk of severe kidney disease. These are tendencies across groups, not predictions for any one person.
Because the features arrive at different ages, BBS is often pieced together over time. Extra digits or enlarged kidneys may be seen on a pregnancy ultrasound or at birth, weight gain usually begins in the first years of life, and the retinal disease is typically diagnosed between about ages 5 and 12. Night blindness is often the first vision symptom, though parents may not notice it; a child who is clumsy in dim light or bumps into things may be the clue. Vision problems in a child who also has extra digits, early weight gain or kidney differences found before birth should prompt testing for BBS. Clinicians look for a set of primary features (retinal disease, extra digits, obesity, genital or kidney differences, learning difficulties) and secondary ones, and genetic testing usually settles the question. A gene panel covering the BBS genes and look-alike conditions finds the cause in more than 90 percent of people who meet the clinical criteria. Confirming the gene matters in practice: it separates BBS from similar conditions such as Alström syndrome, which also causes early vision loss and obesity but no extra digits, and adds heart muscle and hearing problems. It can also qualify someone for specific treatment or research studies, and through genetic counseling it lets relatives learn whether they are carriers. Eye specialists often confirm the retinal disease with an electroretinogram (ERG), a test that records how the retina's light-sensing cells respond to flashes of light, because their function can fall before changes are visible in an eye exam. A full first assessment also includes a kidney ultrasound, blood and urine tests of kidney function, blood pressure, blood sugar and cholesterol, hormone checks and a developmental assessment.
No treatment corrects the underlying genetic fault, so care is aimed at each feature. It works best when coordinated by a team that may include eye, kidney, hormone, nutrition and developmental specialists, ideally with input from a center that sees people with BBS. No therapy currently slows the retinal disease, but a great deal can be done around it. Most people with BBS also have focusing problems that glasses correct, and tinted lenses can ease light sensitivity. Cataracts often develop in early adulthood and can be removed surgically. As vision declines, low-vision aids, screen-reading and magnification apps, Braille, orientation and mobility training, a white cane or a guide dog help people stay independent. Setting up school and work adaptations before vision worsens makes each change easier to absorb. Weight management starts with structured changes to eating and activity that involve the whole family and are adapted to the person's vision and developmental level. Many people with BBS feel intense, persistent hunger, which makes diet alone hard to sustain. Setmelanotide (Imcivree) is a once-daily injection under the skin that activates the melanocortin 4 (MC4) receptor, part of a brain pathway that regulates hunger and energy use and works poorly in BBS. It is approved in the United States for people with BBS from age 2. In its main trial, body mass index (BMI, a measure of weight relative to height) fell by about 8 percent on average after a year, and about 4 in 10 people lost at least 10 percent. Its main trade-offs are darkening of the skin and moles (so skin checks are part of treatment), nausea and injection-site reactions, and the need to watch mood, since depression has been reported. Newer weight-loss medicines such as semaglutide have not yet been studied specifically in BBS, and weight-loss surgery needs careful evaluation by an experienced team. Many related problems are treated as they would be in anyone else: medicines for high blood pressure and diabetes, testosterone for boys and men with low hormone levels, thyroid hormone when needed, and kidney care that follows standard chronic kidney disease guidelines, including dialysis or a transplant if the kidneys fail. Extra digits are usually removed in early childhood. Speech therapy, educational support and psychological care help with learning, communication and behavior.
BBS is lifelong, and its features unfold over years. Vision changes most during childhood and adolescence: night vision goes first, side vision then narrows toward tunnel vision, and central vision blurs, making reading and fine tasks harder. Most people meet the definition of legal blindness or severe visual impairment by their mid-teens, although some keep useful vision longer. Weight, blood pressure, blood sugar and cholesterol need attention from childhood, because type 2 diabetes and high blood pressure tend to appear at younger ages than in the general population. Sleep apnea is common. Kidney involvement ranges from none to severe. About 5 to 6 percent of people with BBS reach kidney failure, but milder chronic kidney disease is more common, and some people's kidneys cannot concentrate urine, so they pass large amounts and feel thirsty. Learning and independence vary widely. Learning difficulties are common, while about one in five to one in four people have an intellectual disability. Anxiety, a strong need for routine and social difficulties are also frequent, and psychological support can help at every age. Many men with BBS have low testosterone and some have difficulty fathering children, though some have; fertility in women often appears preserved. Expert guidance recommends checks at least once a year of vision, weight and metabolism, kidney function and blood pressure, adjusted to how the condition is behaving. Anyone with BBS who needs surgery should tell the anesthesia team in advance, because managing the airway can be more difficult, especially in adults. Genetic counseling and rare-disease support organizations can help families plan for the years ahead.
Ask for a specialist or genetics evaluation if a child has night blindness, clumsiness in dim light or declining vision together with extra fingers or toes, rapid weight gain in early childhood or kidney differences found before birth. For someone already diagnosed, raise new or increasing thirst, drinking at night, heavier urination or new bedwetting with the care team, since these can signal kidney changes or diabetes, and mention loud snoring with pauses in breathing or daytime sleepiness, which can point to sleep apnea. Contact the care team promptly about vomiting, diarrhea or being unable to keep fluids down, because kidneys that cannot conserve water make dehydration develop faster. For someone taking setmelanotide, tell the prescriber promptly about new or worsening low mood.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Bardet-Biedl Syndrome is like, what's helped you, or ask the community a question.